A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
Clinical trial NCT06213311 · RECRUITING
Trial details
- NCT number
- NCT06213311
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2027-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.